Dr. Bernd Schulte, Dipl. Public Health

Wissenschaftlicher Mitarbeiter, stv. Geschäftsführer

Zentrum für Interdisziplinäre Suchtforschung der Universität Hamburg

Martinistraße 52
20246 Hamburg

Tel. 0049 40 / 7410-59438

Fax 0049 40 / 7410-58351
eMail: b.schulte@uke.de


seit 2011wissenschaftlicher Mitarbeiter am Zentrum für Interdisziplinäre Suchtforschung, Universität Hamburg
2009-2011  Resident Twinning Advisor, Institut für Therapieforschung, München
2003-2009wissenschaftlicher Mitarbeiter am Zentrum für Interdisziplinäre Suchtforschung, Universität Hamburg
bis 2003Public Health Studium HAW Hamburg, Schwerpunkt Epidemiologie und klinische Psychologie


  • Versorgungs- und Implementierungsforschung
  • Infektionsepidemiologie
  • Public Health




  • Kahl J, Holl J, Grundmann J, Lotzin A, Hiller P, Schroeder K, Schulte B, Barnow S, Schäfer I (2020) Emotion Regulation as a Mediator between Childhood Abuse and Neglect and Posttraumatic Stress Disorder in Women with Substance Use Disorders. Substance Use & Misuse, DOI: 10.1080/10826084.2020.1797805
  • Schulte B, Schmidt CS, Manthey J, Strada L, Christensen S, Cimander K, Görne H, Khaykin P, Scherbaum N, Walcher S, Mauss S, Schäfer I, Verthein U, Rehm J,  Reimer J (2020) Clinical and Patient-Reported Outcomes of Direct-Acting Antivirals for the Treatment of Chronic Hepatitis C Among Patients on Opioid Agonist Treatment: A Real-world Prospective Cohort Study. Open Forum Infectious Diseases, https://doi.org/10.1093/ofid/ofaa317
  • Jané-Llopis E, Anderson P, Piazza M, O'Donnell A, Gual A, Schulte B, Pérez Gómez A, de Vries H,  Natera Rey G, Kokole D, Bustamante I, Braddick F, Mejía Trujillo J, Solovei A, Pérez De León A, Kaner E, Matrai S, Manthey J, Mercken L, López-Pelayo H, Rowlands G, Schmidt C, Rehm J (2020) Implementing primary healthcare-based measurement, advice and treatment for heavy drinking and comorbid depression at the municipal level in three Latin American countries: final protocol for a quasiexperimental study (SCALA study). BMJ Open, http://dx.doi.org/10.1136/bmjopen-2020-038226
  • Verthein U, Buth S, Daubmann A, Martens MS,  Schulte (2020) Trends in risky prescriptions of opioid analgesics from 2011 to 2015 in Northern Germany. Journal of Psychopharmacology, doi: 10.1177/0269881120936544
  • O’Donnell A, Hanratty B, Schulte B, Kaner E (2020) Patients’ experiences of alcohol screening and advice in primary care: a qualitative study. BMC Fam Pract 21, 68. https://doi.org/10.1186/s12875-020-01142-9
  • Reiß M, Schulte B, Schmidt CS, Carstens A, Görne H, Kreibich R, Tietje W, Weber B, Schnell T, Verthein U (2020) Selbst- und Fremdbeurteilung von Depressivität bei opioidabhängigen Patienten in Substitutionsbehandlung. Suchttherapie, 21: 25-31. DOI: 10.1055/a-1032-6735
  • Schulte B, O’Donnell A, Lahusen H, Lindemann C, Prilutskaya M, Yussopov O, Kaliyeva Z, Martens MS, Verthein U (2020) Feasibility of alcohol screening and brief intervention in primary health care in Kazakhstan: study protocol of a pilot cluster randomised trial. Pilot Feasibility Stud; 6:3 doi:10.1186/s40814-019-0547-x
  • Manthey J, Lindemann C, Kraus L, Reimer J, Verthein U, Schulte B, Rehm J (2020) The potential effects of an extended alcohol withdrawal treatment programme on morbidity and mortality among inpatients in the German city of Bremen: a simulation study. Subst Abuse Treat Prev Policy; 2:15. doi: 10.1186/s13011-019-0249-7
  • Manthey J, Lindemann C, Verthein U, Frischknecht U, Kraus L, Reimer J, Grün A, Kiefer F, Schulte B, Rehm J (2020) Versorgung von Personen mit riskantem Alkoholkonsum und schwerer Alkoholkonsumstörung in Bremen: bedarfsgerecht und leitlinienkonform? Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz; 63:122-130. doi: 10.1007/s00103-019-03072-z
  • Schulte B, Lindemann C, Buchholz A, Rosahl A, Härter M, Kraus L, Kiefer F, Frischknecht U, Hoffmann S, Wensing M, O'Donnell A, Manthey J, Rehm J, Schäfer I, Verthein U, Reimer J (2019) Tailored interventions to support the implementation of the German national guideline on screening, diagnosis and treatment of alcohol-related disorders: a project protocol. SUCHT; 65: 373-381
  • Heddaeus D, Dirmaier J, Brettschneider C, Daubmann A, Grochtdreis T, von dem Knesebeck O, König HH, Löwe B, Maehder K, Porzelt S, Rosenkranz M, Schäfer I, Scherer M, Schulte B, Wegscheider K, Weigel A, Werner S, Zimmermann T, Härter M (2019) Study protocol for the COMET study: a cluster-randomised, prospective, parallel-group, superiority trial to compare the effectiveness of a collaborative and stepped care model versus treatment as usual in patients with mental disorders in primary care. BMJ Open;9:e032408. doi: 10.1136/bmjopen-2019-032408
  • Schulte B, Schmidt CS, Strada L, Rosenkranz M, Schäfer I, Verthein U, Reimer
    J (2019) Hepatitis C Virus Prevalence and Incidence in a Large Nationwide Sample of Patients in Opioid Substitution Treatment in Germany: A Prospective Cohort Study. Clin Infect Dis. doi: 10.1093/cid/ciz661
  • Schulte B, Kaner EFS, Beyer F, Schmidt CS, O'Donnell A (2019) Study protocol for a
    systematic review of evidence for digital interventions for comorbid excessive
    drinking and depression in community-dwelling populations. BMJ Open; 17;9:e031503. doi: 10.1136/bmjopen-2019-031503
  • Kraus L, Seitz NN, Schulte B, Cremer-Schaeffer P, Braun B, Verthein U, Pfeiffer-Gerschel T (2019) Schätzung der Anzahl von Personen mit einer Opioidabhängigkeit. Dtsch Arztebl Int 2019; 116: 137–43
  • Strada L, Schmidt CS, Rosenkranz M, Verthein U, Scherbaum N, Reimer J, Schulte B (2019) Factors associated with health-related quality of life in a large national sample of patients receiving opioid substitution treatment in Germany: A cross-sectional study. Substance Abuse Treatment, Prevention, and Policy; 14:2
  • Heddaeus D, Dirmaier J, Daubmann A, Grochtdreis T, König HH, Löwe B, Maehder K, Porzelt S, Rosenkranz M, Schäfer I, Scherer M, Schulte B, von dem Knesebeck O, Wegscheider K, Weigel A, Werner S, Zimmermann T und Härter M (2019). Erprobung eines integrierten und gestuften Behandlungsmodells für psychische Störungen und Komorbiditäten im Hamburger Netzwerk für Versorgungsforschung. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. doi:10.1007/s00103-018-2865-1       
  • Fraser H, Martin NK, Brummer-Korvenkontio H, Carrieri P, Dalgard O, Dillon J, Goldberg D, Hutchinson S, Jauffret-Roustide M, Kåberg M, Matser AA, Midgard H, Mravcik V, Øvrehus A, Prins M, Reimer J, Robaeys R, Schulte B, van Santen DK, Zimmermann R, Vickerman P, Hickman M (2018) Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe. Journal of hepatology, 68: 402-411
  • Grundmann J, Lincoln T, Lüdecke D, Bong S, Schulte B, Verthein U & Schäfer I (2018) Traumatic Experiences, Revictimization and Posttraumatic Stress Disorder in German Inpatients Treated for Alcohol Dependence. Substance Use & Misuse, 53: 677-685
  • Strada L, Franke GH, Schulte B, Reimer J, Verthein U. (2017) Development of OSTQOL: A Measure of Quality of Life for Patients in Opioid Substitution Treatment. Eur Addict Res; 23(5):238-248.
  • Rehm J, Anderson P, Prieto JAA, Armstrong I, Aubin HJ, Bachmann M, Bastus NB, Brotons C, Burton R, Cardoso M, Colom J, Duprez D, Gmel G, Gual A, Kraus L, Kreutz R, Liira H, Manthey J, Møller L, Okruhlica L, Roerecke M, Scafato E, Schulte B, Segura-Garcia L, Shield KD, Sierra C, Vyshinskiy K, Wojnar M, Zarco J (2017) Towards new recommendations to reduce the burden of alcohol-induced hypertension in the European Union. BMC Med 28:173. doi: 10.1186/s12916-017-0934-1
  • Strada L, Vanderplasschen W, Buchholz A,  Schulte B, Muller AE, Verthein U, Reimer J. (2017) Measuring quality of life in opioid-dependent people: a systematic review of assessment instruments. Qual Life Res. https://doi.org/10.1007/s11136-017-1674-6
  • Anderson P, O'Donnell A, Kaner E, Gual A, Schulte B, Perez-Gomez A, deVries H, Natera G, Rehm J (2017) Scaling-up primary health care-based prevention and management of alcohol use disorder at the municipal level in middle-income countries in Latin America: Background and pre-protocol for a three-country quasi-experimental study. F1000Research 2017, 6:311 doi: 10.12688/f1000research.11173.1
  • Kraus L, Schulte B, Manthey J, Rehm J (2016) Alcohol screening and alcohol interventions among patients with hypertension in primary health care: an empirical survey of German general practitioners. Addiction Research & Theory: 25:4, 285-92
  • Rehm J, Prieto J, Beier M, Duhot D, Rossi A, Schulte B, Zarco J, Aubin HJ, Bachmann M, Grimm C, Kraus L, Manthey J, Scafato E, Gual A (2016) The role of alcohol in the management of hypertension in patients in European primary health care practices - A survey in the largest European Union countries. BMC Family Practice 17(1); doi: 10.1186/s12875-016-0529-5
  • Kraus L, Hay G, Richardson C, Yargic I, Ilhan M, Ay P, Karasahin F, Pinarci M, Tuncoglu T, Piontek D and Schulte B (2016) Estimating high-risk cannabis and opiate use in Ankara, Istanbul and Izmir. Drug and Alcohol Review, doi: 10.1111/dar.12447
  • Schmidt CS, Schulte B, Seo HN, Kuhn S, O Donnell A, Kriston L, Verthein U, Reimer J. (2016). Meta-analysis on the effectiveness of alcohol screening with brief interventions for patients in emergency care settings. Addiction. 2015 Dec 5. doi: 10.1111/add.13263
  • Schulte B, Schmidt CS, Strada L, Götzke C, Hiller P, Fischer B, Reimer J (2016). Non-prescribed use of opioid substitution medication: Patterns and trends in sub-populations of opioid users. Int J Drug Pol doi:10.1016/j.drugpo.2015.12.024
  • Strada L, Schulte B, Schmidt CS, Verthein U, Cremer-Schaeffer P, Kru?ckeberg S, Reimer J (2015) Epidemiology of hepatitis C virus infection among people receiving opioid substitution therapy (ECHO): Study protocol. BMC Infectious Diseases (2015) 15:563 DOI 10.1186/s12879-015-1307-z
  • O’Donnell A, Anderson P, Newbury-Birch D, Schulte B, Schmidt C, Reimer J, Kaner E. The impact of brief alcohol interventions in primary healthcare: a systematic review of reviews. Alcohol Alcoholism 2014; 49: 66-78.
  • Schmidt CS, McGovern R, Schulte B, O'Donnell A, Lehmann K, Kuhn S, Schäfer I, Newbury-Birch D, Anderson P, Kaner E, Reimer J. Brief Alcohol Interventions in Social Service and Criminal Justice Settings: A Critical Commentary. Br J Soc Work 2014 doi: 10.1093/bjsw/bcu100
  • Schulte B, O`Donnell A, Kastner S, Schmidt CS, Schäfer I, Reimer J. Alcohol screening and brief intervention in workplace settings and social services: A comparison of literature. Front. Psychiatry 2014 doi: 10.3389/fpsyt.2014.00131
  • Schäfer I, Gromus L, Atabaki A, Pawlis S, Verthein U, Reimer J, Schulte B, Martens M. Are experiences of sexual violence related to special needs in patients with substance use disorders? A study in opioid-dependent patients. Addictive Behaviors 2014: 39; 1691–94
  • Mravcik V, Strada L, Reimer J, Schulte B. Hepatitis C treatment uptake and adherence among injecting drug users in the Czech Republic. Epidemiologie, mikrobiologie, imunologie. 2014 Fall;63(4):265-269
  • Schulte B, Gonzales-Saiz F, Jeschke P, Reimer J, Schäfer I, Walcher S, Weber B, Verthein U. Die Opiate-Dosage-Adequacy-Scale (ODAS) für die Beurteilung der Angemessenheit der Buprenorphindosierung während der Opiatsubstitution. Suchttherapie 2014; 15: 35-42.
  • Schmidt CS, Schön D, Schulte B, Lüth S, Polywka S, Reimer J. Viral hepatitis in alcohol-dependent inpatients – Prevalence, risk factors and treatment uptake. Journal of Addiction Medicine 2013; 7:417-21. doi: 10.1097/ADM.0b013e3182a50817
  • Mravcík V, Strada L, Stolfa J, Bencko V, Groshkova T, Reimer J, Schulte B. Factors associated with the uptake, adherence and efficacy of hepatitis C treatment among people who inject drugs: a literature review. Patient Preference and Adherence 2013; 7:1067-1075
  • Reimer J, Schmidt CS, Schulte B, Gansefort D, Gölz J, Gerken G, Scherbaum N, Verthein U, Backmund M. Psychoeducation improves hepatitis C virus treatment during opioid substitution therapy: a controlled, prospective multicenter trial.Clin Infect Dis. 2013 Aug;57 Suppl 2:S97-104. doi: 10.1093/cid/cit307.
  • Schulte B, Schmidt CS, Schäfer I, Fischer B, Wedemeyer H, ReimerJ. Structural barriers in the context of opiate substitution treatment in Germany. Substance Abuse, Treatment, Prevention & Policy 2013; 8:26
  • Schulte B, Schmidt CS, Milin S, Farnbacher G, Schäfer I, Hillemacher T, Kiefer F, Bleich S, Reimer J (2013) Barrieren und Möglichkeiten in der Umsetzung von alkoholbezogenen Interventionen in der hausärztlichen Praxis. Suchttherapie 2014; 15: 35-42.
  • Reimer J, Schmidt CS, Schulte B, Gansefort D, Gölz J, Gerken G, Scherbaum N, Verthein U, Backmund M.  Psychoeducation improves hepatitis C virus therapy outcomes in opioid-substituted patients: A controlled, prospective multicentre trial. Clinical infectious diseases 2013; 57 Suppl 2: 97-S104.
  • O’Donnell A, Kaner E, Newbury-Birch D, Schulte B, Schmidt C, Reimer J, Anderson P. Efficacious, effective but still erratic: what will it take to get routine delivery of brief interventions for alcohol in primary healthcare settings? Alcohol & Alcoholism 2013; 49 doi:10.1093/alcalc/agt170
  • Schmidt CS, Schulte B, Wickert C, Thane K, Kuhn S, Verthein U, Reimer J. Non-prescribed use of substitution medication among German drug users – Prevalence, motives and availability. International Journal of Drug Policy,  2013;24:e111-4. doi:10.1016/j.drugpo.2013.04.006
  • Mravcík V, Škacupová K, Orlíková B, Zábranský T, Karachaliou K, Schulte B (2011) Use of gelatine capsules for application of methamphetamine: A new harm reduction approach. Int J Drug Policy 22, 172-173 Abstract
  • Mravcík V, Škarupová K, Orlíková B, Zábranský T, Karachaliou K, Schulte B (2011) Use of gelatine capsules for application of methamphetamine: A new harm reduction approach. Int J Drug Policy 22, 172-173
  • Schulte B, Schütt S, Brack J, Isernhagen K, Deibler P, Dilg C, Verthein U, Haasen C. Reimer J (2010). Successful treatment of chronic hepatitis C virus infection in severely opioid-dependent patients under heroin maintenance. Drug and Alcohol Dependence 109: 248-251
  • Keppler K, Stöver H, Schulte B, Reimer J (2010). Prison health is public health! Problems in adapting and implementing health services for prisoners in Germany.  Bundesgesundheitsblatt 53, 233–244
  • Schulte B, Gansefort D, Stöver H, Reimer J. Strukturelle Hemmnisse in der Substitution und infektiologischen Versorgung Opiatabhängiger. Suchttherapie 2009; 10; 125-130.
  • Haasen C, Schulte B, Vanderplasschen W, Verthein U, Schäfer I, Reimer J: Predictive value of regular cocaine use among opioid-dependent patients for long-term outcome. Addictive Disorders & Their Treatment, 2009; 8:74-79
  • Schulte B, Stöver H, Thane K, Schreiter C, Gansefort D, Reimer J. Substitution treatment and HCV- / HIV-infection in a sample of 31 German prisons for sentenced inmates. International Journal of Prisoner Health 2009; 5: 38-44.
  • Reimer J, Schulte B, Castells X, Schaefer I, Polywka S, Hedrich D, Wiessing L Haasen C, Backmund M, Krausz M (2005). Guidelines for treatment of hepatitis C virus infection in injecting drug users: status quo in the European Union countries. Clinical Infectious Diseases; 40 Suppl5: S373-S378.
  • Reimer J, Schulte B, Schaefer I, Backmund M, Haasen C (2005). Hepatitis C bei Drogengebrauchern. Suchttherapie; 6: 28-30.
  • Hedrich D, Schulte B, Reimer J (2004). Analyse der Leitlinien zur Hepatitis-C-Behandlung in den Ländern der Europäischen Union und Norwegen in Bezug auf den Behandlungszugang von DrogenkonsumentInnen. In: akzept, Deutsche Aidshilfe, LaBAS (Hrsg.): 1. Internationaler Fachtag Hepatitis C Berlin 2004. Innovative Konzepte und Praxis von Prävention und Psychosozialer Betreuung nach Drogengebrauch. Seiten 36-41. Berlin, akzept.
  • Reimer J, Schulte B, Haasen C, Krausz M (2004). Epidemiologie der Sucht. In: Backmund M (Hrsg.). Suchttherapie - Grundlagen, Klinik, Standards: Leitfaden für Praxis und Fortbildung. Seiten V1 - V11 (75 Seiten). Landsberg: Ecomed.